XML 33 R21.htm IDEA: XBRL DOCUMENT v3.21.2
SEGMENT REPORTING (Tables)
9 Months Ended
Sep. 30, 2021
Segment Reporting [Abstract]  
SCHEDULE OF BUSINESS INTERESTS INTO REPORTABLE SEGMENTS

 SCHEDULE OF BUSINESS INTERESTS INTO REPORTABLE SEGMENTS

Nine Months Ended

September 30, 2021

  Trxade, Inc.  

Community Specialty Pharmacy,

LLC

   Integra Pharma, LLC   Other   Total 
Revenue  $3,653,269   $1,287,296   $2,511,270   $49,700   $7,501,535 
Gross Profit  $3,652,015   $123,470   $(319,104)  $49,362   $3,505,743 
Segment Assets  $1,487,657   $(404,174)  $563,396   $3,867,221   $5,514,101 
Segment Profit (Loss)  $1,511,809   $(89,025)  $(2,500,032)  $(3,454,295)  $(4,531,543)

 

Nine Months Ended

September 30, 2020

  Trxade, Inc.   Community Specialty Pharmacy, LLC   Integra Pharma, LLC   Other   Total 
Revenue  $4,268,619   $1,287,197   $9,548,512   $23,898   $15,128,226 
Gross Profit  $4,268,619   $119,946   $1,162,030   $23,615   $5,574,210 
Segment Assets  $1,828,345   $257,495   $3,118,945   $6,649,226   $11,854,011 
Segment Profit (Loss)  $2,655,734   $(88,756)  $762,149   $(3,553,020)  $(223,893)